2024-04-012025-03-312025-03-31false06512755CAMPBELL ORTHODONTICS LIMITED2025-12-1686230falseiso4217:GBPxbrli:pure065127552024-03-31065127552025-03-31065127552024-04-012025-03-31065127552023-03-31065127552024-03-31065127552023-04-012024-03-3106512755bus:SmallEntities2024-04-012025-03-3106512755bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3106512755bus:AbridgedAccounts2024-04-012025-03-3106512755bus:PrivateLimitedCompanyLtd2024-04-012025-03-3106512755core:WithinOneYear2025-03-3106512755core:AfterOneYear2025-03-3106512755core:WithinOneYear2024-03-3106512755core:AfterOneYear2024-03-3106512755core:ShareCapital2025-03-3106512755core:SharePremium2025-03-3106512755core:RevaluationReserve2025-03-3106512755core:OtherReservesSubtotal2025-03-3106512755core:RetainedEarningsAccumulatedLosses2025-03-3106512755core:ShareCapital2024-03-3106512755core:SharePremium2024-03-3106512755core:RevaluationReserve2024-03-3106512755core:OtherReservesSubtotal2024-03-3106512755core:RetainedEarningsAccumulatedLosses2024-03-3106512755core:LandBuildings2025-03-3106512755core:PlantMachinery2025-03-3106512755core:Vehicles2025-03-3106512755core:FurnitureFittings2025-03-3106512755core:OfficeEquipment2025-03-3106512755core:NetGoodwill2025-03-3106512755core:IntangibleAssetsOtherThanGoodwill2025-03-3106512755core:ListedExchangeTraded2025-03-3106512755core:UnlistedNon-exchangeTraded2025-03-3106512755core:LandBuildings2024-03-3106512755core:PlantMachinery2024-03-3106512755core:Vehicles2024-03-3106512755core:FurnitureFittings2024-03-3106512755core:OfficeEquipment2024-03-3106512755core:NetGoodwill2024-03-3106512755core:IntangibleAssetsOtherThanGoodwill2024-03-3106512755core:ListedExchangeTraded2024-03-3106512755core:UnlistedNon-exchangeTraded2024-03-3106512755core:LandBuildings2024-04-012025-03-3106512755core:PlantMachinery2024-04-012025-03-3106512755core:Vehicles2024-04-012025-03-3106512755core:FurnitureFittings2024-04-012025-03-3106512755core:OfficeEquipment2024-04-012025-03-3106512755core:NetGoodwill2024-04-012025-03-3106512755core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106512755core:ListedExchangeTraded2024-04-012025-03-3106512755core:UnlistedNon-exchangeTraded2024-04-012025-03-3106512755core:MoreThanFiveYears2024-04-012025-03-3106512755core:Non-currentFinancialInstruments2025-03-3106512755core:Non-currentFinancialInstruments2024-03-3106512755dpl:CostSales2024-04-012025-03-3106512755dpl:DistributionCosts2024-04-012025-03-3106512755core:LandBuildings2024-04-012025-03-3106512755core:PlantMachinery2024-04-012025-03-3106512755core:Vehicles2024-04-012025-03-3106512755core:FurnitureFittings2024-04-012025-03-3106512755core:OfficeEquipment2024-04-012025-03-3106512755dpl:AdministrativeExpenses2024-04-012025-03-3106512755core:NetGoodwill2024-04-012025-03-3106512755core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106512755dpl:GroupUndertakings2024-04-012025-03-3106512755dpl:ParticipatingInterests2024-04-012025-03-3106512755dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3106512755core:ListedExchangeTraded2024-04-012025-03-3106512755dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3106512755core:UnlistedNon-exchangeTraded2024-04-012025-03-3106512755dpl:CostSales2023-04-012024-03-3106512755dpl:DistributionCosts2023-04-012024-03-3106512755core:LandBuildings2023-04-012024-03-3106512755core:PlantMachinery2023-04-012024-03-3106512755core:Vehicles2023-04-012024-03-3106512755core:FurnitureFittings2023-04-012024-03-3106512755core:OfficeEquipment2023-04-012024-03-3106512755dpl:AdministrativeExpenses2023-04-012024-03-3106512755core:NetGoodwill2023-04-012024-03-3106512755core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3106512755dpl:GroupUndertakings2023-04-012024-03-3106512755dpl:ParticipatingInterests2023-04-012024-03-3106512755dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3106512755core:ListedExchangeTraded2023-04-012024-03-3106512755dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3106512755core:UnlistedNon-exchangeTraded2023-04-012024-03-3106512755core:NetGoodwill2025-03-3106512755core:IntangibleAssetsOtherThanGoodwill2025-03-3106512755core:LandBuildings2025-03-3106512755core:PlantMachinery2025-03-3106512755core:Vehicles2025-03-3106512755core:FurnitureFittings2025-03-3106512755core:OfficeEquipment2025-03-3106512755core:AfterOneYear2025-03-3106512755core:WithinOneYear2025-03-3106512755core:ListedExchangeTraded2025-03-3106512755core:UnlistedNon-exchangeTraded2025-03-3106512755core:ShareCapital2025-03-3106512755core:SharePremium2025-03-3106512755core:RevaluationReserve2025-03-3106512755core:OtherReservesSubtotal2025-03-3106512755core:RetainedEarningsAccumulatedLosses2025-03-3106512755core:NetGoodwill2024-03-3106512755core:IntangibleAssetsOtherThanGoodwill2024-03-3106512755core:LandBuildings2024-03-3106512755core:PlantMachinery2024-03-3106512755core:Vehicles2024-03-3106512755core:FurnitureFittings2024-03-3106512755core:OfficeEquipment2024-03-3106512755core:AfterOneYear2024-03-3106512755core:WithinOneYear2024-03-3106512755core:ListedExchangeTraded2024-03-3106512755core:UnlistedNon-exchangeTraded2024-03-3106512755core:ShareCapital2024-03-3106512755core:SharePremium2024-03-3106512755core:RevaluationReserve2024-03-3106512755core:OtherReservesSubtotal2024-03-3106512755core:RetainedEarningsAccumulatedLosses2024-03-3106512755core:NetGoodwill2023-03-3106512755core:IntangibleAssetsOtherThanGoodwill2023-03-3106512755core:LandBuildings2023-03-3106512755core:PlantMachinery2023-03-3106512755core:Vehicles2023-03-3106512755core:FurnitureFittings2023-03-3106512755core:OfficeEquipment2023-03-3106512755core:AfterOneYear2023-03-3106512755core:WithinOneYear2023-03-3106512755core:ListedExchangeTraded2023-03-3106512755core:UnlistedNon-exchangeTraded2023-03-3106512755core:ShareCapital2023-03-3106512755core:SharePremium2023-03-3106512755core:RevaluationReserve2023-03-3106512755core:OtherReservesSubtotal2023-03-3106512755core:RetainedEarningsAccumulatedLosses2023-03-3106512755core:AfterOneYear2024-04-012025-03-3106512755core:WithinOneYear2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106512755core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3106512755core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3106512755core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3106512755core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3106512755core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3106512755core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3106512755core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3106512755core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3106512755core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3106512755core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3106512755core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3106512755core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3106512755core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3106512755core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3106512755core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3106512755core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3106512755core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3106512755core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3106512755bus:Director12024-04-012025-03-31

CAMPBELL ORTHODONTICS LIMITED

Registered Number
06512755
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

CAMPBELL ORTHODONTICS LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

CAMPBELL, Alethia Elisia

Company Secretary

ANDERSON, John Stuart

Registered Address

81-83 Park Road Peterborough Park Road
Peterborough
PE1 2TN

Registered Number

06512755 (England and Wales)
CAMPBELL ORTHODONTICS LIMITED
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets311,68319,638
11,68319,638
Current assets
Debtors6160,523167,504
Cash at bank and on hand91,91854,940
252,441222,444
Creditors amounts falling due within one year7(95,278)(92,946)
Net current assets (liabilities)157,163129,498
Total assets less current liabilities168,846149,136
Provisions for liabilities8(2,921)(4,909)
Net assets165,925144,227
Capital and reserves
Called up share capital11
Profit and loss account165,924144,226
Shareholders' funds165,925144,227
The financial statements were approved and authorised for issue by the Director on 16 December 2025, and are signed on its behalf by:
CAMPBELL, Alethia Elisia
Director
Registered Company No. 06512755
CAMPBELL ORTHODONTICS LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss. The financial statements are prepared in Sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)Straight line (years)
Plant and machinery25-
Fixtures and fittings-20
Office Equipment-25
2.Average number of employees

20252024
Average number of employees during the year98
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 2451,233
At 31 March 2551,233
Depreciation and impairment
At 01 April 2431,595
Charge for year7,955
At 31 March 2539,550
Net book value
At 31 March 2511,683
At 31 March 2419,638
4.Impairment of fixed asset investments
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
5.Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables143,894154,336
Other debtors1,2201,220
Prepayments and accrued income15,40911,948
Total160,523167,504
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables80,88365,606
Bank borrowings and overdrafts1,410519
Taxation and social security12,98526,821
Total95,27892,946
8.Provisions for liabilities
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises

2025

2024

££
Net deferred tax liability (asset)2,9214,909
Total2,9214,909
9.Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual agreement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
10.Related party transactions
During the year the directors made available a loan to the company of £516 (2024: £519). Interest has been charged on this balance at the UK market rate. The loan is repayable on demand.